Abstract: L-DOPA IS toxic to catecholamine neurons in culture, but the toxicity is reduced by exposure to astrocytes. We tested the effect of L-DOPA on dopamine neurons using postnatal ventral midbrain neuron/cortical astrocyte cocultures in serum-free, glia-conditioned medium. L-DOPA (50 tiM) protected against dopamine neuronal cell death and increased the number and branching of dopamine processes. In contrast to embryonically derived glia-free cultures, where L-DOPA is toxic, postnatal midbrain cultures did not show toxicity at 200 1iM L-DOPA. The stereoisomer D-DOPA (50-400 btM) was not neurotrophic. The aromatic amino acid decarboxylase inhibitor carbidopa (25~zM) did not block the neurotrophic effect. These data suggest that the neurotrophic effect of L-DOPA is stereospecific but independent of the production of dopamine. However, L-DOPA increased the level of glutathione. Inhibition of glutathione peroxidase by Lbuthionine sulfoximine (3 1iM for 24 h) blocked the neurotrophic action of L-DOPA. N-Acetyl-L-cysteine (250 1iM for 48 h), which promotes glutathione synthesis, had a neurotrophic effect similar to that of L-DOPA. These data suggest that the neurotrophic effect of L-DOPA may be mediated, at least in part, by elevation of glutathione content. Key Words: L-DOPA-Glia-Glutathione-Parkinson's disease-Dopamine neurons.
The effects of L-DOPA on dopamine (DA) neurons are quite different in vivo and in vitro. Whereas relatively low levels (25 jiM) of L-DOPA are toxic in culture (Melamed, 1986; Mena et al., 1992 Mena et al., , 1993 Mytilineou et al., 1993; Pardo et al., 1995) , the drug has not been seen to damage DA neurons in healthy animals (Hefti et al., 1981; Perry et al., 1984; Yurek et al., 1991; Blunt et al., 1993) or humans (Quinn et al., 1986) . As L-DOPA is the most effective compound for symptomatic treatment of Parkinson' s disease (PD), its influence on the progression of the disease is particularly important. Although some reports have indicated increased fluctuations and dyskinesia related to the duration of the L-DOPA treatment (Lesser et al., 1979) , other studies have found no evidence of negative impact (Markham and Diamond, 1986; Blint et al., 1988; Uitti et al., 1993) .
Previous studies on L-DOPA toxicity in culture have used embryonically derived cells grown in the presence of a very low level of glia (<5%), although in the brain DA neurons are enveloped by glia. To investigate the modulatory effects of glia on L-DOPA toxicity, we have used a coculture system of postnatal midbrain DA neurons and cortical astrocytes, a target area of midbrain DA projections. The protective role of glia has been demonstrated in experiments showing that medium preconditioned by glia protects embryonically derived midbrain cultures from L-DOPA toxicity (Mena et al., 1996) . The midbrain neurons/cortical glia coculture system used in the present report is advantageous for this study because it produces a high number of mature midbrain neurons generally 30-40% of the neurons are tyrosine hydroxylase (TH) -positive, as compared with <4% typical of embryonically derived cultures]. We suggest that this system, which has previously been used to provide insights into the mechanisms of methamphetamine neurotoxicity (Cubells et al., 1994) and the role of superoxide dismutase (SOD) in protection from cell death (Przedborski et al., 1996) , is appropriate for studying the effects on cell survival and the mechanisms of action of L-DOPA. 
MATERIALS AND METHODS

Materials
Coculture of postnatal DA neurons/cortical astrocytes
Cultures of ventral midbrain neurons from postnal day 1-2 rats were prepared as in related studies (Rayport et al., 1992; Rayport and Suizer, 1995; Pothos et al., 1996; Przedborski et al., 1996) except that serum-free medium was used as recently described (Mena et al., 1997) . Astrocyte monolayers were prepared from the rostral half of the cerebral cortex in ice-cold calcium-and magnesium-free phosphatebuffered saline on postnatal day 2. The chunks of tissue were dissociated with 20 U/ml papain in 1 mM cysteine, 0.001% phenol red, 500 jiM kynurenate, 116 mM NaCl, 5.4 mM KO, 26 mM NaHCO 5, 2 mM NaH2PO4, 1 mM magnesium phosphate, 500 jiM EDTA, and 25 mM glucose, pH 7.3. Cells were plated a density of 150,000 per well and fed with medium containing 90% minimal essential medium, 10% calf serum, 1.83 mM glucose, 5 jig/ml bovine pancreatic insulin, 500 jiM glutamine, 0.6 U/mI penicillin, and 60 jig! ml Streptomycin. 5-Flurodeoxyuridine (11 jiM with 55 jiM uridine) was added 4-5 days after plating, to prevent proliferation of oligodendrocytes.
After 2 weeks in culture, midbrain neurons were plated onto glial monolayers. Twenty-four hours before plating, the glial medium was replaced by serum-free medium containing 47% minimal essential medium, 40% Dulbecco's modified Eagle's medium, 10% Ham's F-12 nutrient medium, 18.9 mM glucose, 0.25% albumin, 500 jiM glutamine, 100 jig! ml transferrin, 15 jiM putrescine, 30 nM triiodothyronine, 25 jig/ml insulin, 200 nM progesterone, 125 nM corticosterone, 5 j.tg/ml SOD, 10 j.tg/ml catalase, and 500 jiM kynurenate. On the next day, the tissue was dissociated, and 80,000 cells, resuspended in serum-free glia conditioned medium, were plated per well. During the following 24 h, cultures were exposed to 5-fluorodeoxyuridine and maintained in serum-free medium at 37°Cin 5% CO2.
Experimental designs
Dose-dependent effects of L-DOPA were studied in postnatal cocultures grown in serum-free medium and treated with L-DOPA (0, 25, 50, 100, 200, and 400 jiM) for 48 h at day 5 in vitro.
The effects of L-DOPA and D-DOPA were compared in cultures grown as above and treated with one of the two stereoisomers at concentrations of 50 and 400 jiM for 48 h. These two concentrations were chosen because we found that L-DOPA shows neurotrophic activity with the lower concentration and neurotoxic properties at the higher concentration (see below).
The neurotrophic properties of L-DOPA on cell survival were further investigated in cultures treated on the third day after plating with 50 jiM L-DOPA for either 24 h or 4 days. We investigated whether the neurotrophic activity of L-DOPA is due to itself or to its metabolite DA, in cultures treated with 50 jiM L-DOPA or 50 ‚aM L-DOPA with 25 pM carbidopa. Previously, we found by HPLC with electrochemical detection that 25 ‚aM carbidopa blocked the conversion of L-DOPA to DA in our culture conditions (Mena et al., 1997) .
The interaction betweenL-DOPA and GSH was examined.
Cells maintained in culture for 5 days were treated with GSH (200 and 400 ‚aM) and with the GSH precursor, L-NAC (250 and 500 ‚aM), for 2 days or with a GSH synthesis inhibitor, BSO (3 ‚aM), for 24 h. The effects of L-DOPA (50 ‚aM) on GSH intracellular levels were examined in cocultures treated with L-DOPA for 24 h.
Measurement of levels of quinones
Extracellular quinones, which indicate extracellular L-DOPA autooxidation, were evaluated according to the spectrometric measurement of the optical density at 490 nm in the culture medium (Mena et al., 1992 (Mena et al., , 1993 .
Cell culture immunocytochemistry
DA neurons in ventral midbrain cultures were identified by TH immunohistochemistry as previously described (Rayport et al., 1992; Przedborski et al., 1996) . In brief, cultures were fixed with 4% paraformaldehyde, washed in Tris-buffered saline (0.1 M Tris-HC1 in 9 g/L NaC1, pH 7.4), permeabilized with 0.1% Triton X-100 (Sigma), and incubated at 4°C for 48 h in a 1:640 dilution of monoclonal anti-TH antiserum (Boehringer Mannheim) in Tris-buffered saline containing 0.1% Triton X-100 and 10% normal horse serum. The secondary antibody was a biotinylate-conjugated monoclonal anti-mouse antibody (1:200) and a horseradish-conjugated avidin/biotin complex (Vector Laboratories); immunostaining was revealed by 3,3 '-diaminobenzidine/H2O2. To assess the specificity of TH immunostaining, the primary or the secondary antibody was omitted.
Glutathione level measurements
Glutathione (GSH) levels were measured according to the method of Tietze (1969) . In brief, 2 X 106 cells were washed twice with phosphate-buffered saline, lysed in 3% perchloric acid for 15 min at 4°C,and centrifuged, and supernatants were neutralized with 9 volumes of 5 mM EDTA in 0.1 M NaH2PO4, pH 7.5. Glutathione content was measured by addition of 5,5 '-dithio-bis (2-nitrobenzoïc acid), and the reaction was monitored at 412 nm. GSH content is expressed as a function of total proteins in the cell extract. Proteins were quantified in the pellet by the method of Bradford (1976) .
Cell counts and statistics
Results are expressed as mean ±SEM values for three to six independent experiments, and each data point corresponds to four or more cultures derived from the same litter. In each culture, eight to 10 consecutive fields (magnification of 100 or 200 X) were counted under phase optics; both the total number of neurons and TH-stained neurons were counted. The number of cells was corrected for area. Results were statistically evaluated for significance by ANOVA for multiple groups followed by Student' s t test. The difference was considered significant when p < 0.05.
RESULTS
Dose-dependent effect of L-DOPA on postnatal cocultures
To observe the effects of L-DOPA, we incubated the cultures for 7 days in serum-free culture medium and added L-DOPA (0, 25, 50, 100, 200, and 400 ‚aM) for 48 h on day 5. In contrast to previous observations with embryonically derived cultures, there was no toxicity or enhanced quinone formation at concentrations Table 1) .
L-DOPA also markedly increased the proliferation of TH-positive neuntes. To compare these effects, we adapted semiquantitative methods for estimating the elaboration of processes in culture (Denis-Donini et al., 1983) . L-DOPA (50 ‚aM) increased the number of TH-positive processes that extended >80 ‚am from a point in the center of the cell body by 177 ± 14% and increased the number of TH-positive neurons that displayed more than three primary processes by 162 ±12% (Fig. 2 ). This process outgrowth was attenuated at levels> 100 ‚aM, but there was no neurotoxicity up to the highest concentration tested, and quinone formation was observed only at 400 ‚aM L-DOPA (Tablei and Fig. 1 ).
Effect of L-DOPA on cell survival of all neurons and TH-positive cells and on quinone formation
From the previous experiment, we selected 50 ‚aM L-DOPA as the optimal concentration for neurotrophic effects. Cultures were treated after 3 days in vitro with 50 ‚aM L-DOPA or solvent for 24 h or 4 days and fixed at 2 h or 4 and 7 days after plating. In both cases, L-DOPA significantly increased the survival of THpositive labeled neurons versus controls (Fig. 3) . No changes in number of TH-unlabeled neurons or in quinone formation were observed (data not shown). 
Comparison of D-and L-DOPA effects
Two experiments were performed to study the dose- DOPA increased quinone levels to 325% of controls, producing a distinct red-brown cast to the medium and damaged cellular morphology ( Fig. 5 and Table 3) . We conclude that D-DOPA has no neurotrophic effect and is toxic at a dose where L-DOPA is neuroprotective.
Effect of carbidopa on L-DOPA response
To examine if the neurotrophic effect that we report was dependent on the dopamine formation from L-DOPA, we cotreated the cultures with L-DOPA with carbidopa. Cocultures exposed to a combination of 25 ‚aM carbidopa [a level that blocks DA formation from L-DOPA in culture (Basma et al., 1995; Mena et al., 1997) ] and 50 ‚aM L-DOPA had a neurotrophic effect similar to the effect of L-DOPA alone. Therefore, conversion of L-DOPA to DA is not required for the neurotrophic effect. However, carbidopa significantly increased the levels of quinones produced (Table 4) .
Effect of L-BSO, L-NAC, and glutathione on L-DOPA response
A different mechanism by which L-DOPA could exert neurotrophic effects is by up-regulating oxygen radical scavenging systems. In particular, L-DOPA has been shown to increase GSH formation in humans (Tohgi et al., 1995) and in culture (Han et al., 1996) . We designed experiments to test whether GSH synthesis itself could provide the neurotrophic effects.
We added exogenous GSH (200 and 400 ‚aM at 5 days in vitro for 48 h) and found an increased elaboration of TH-positive processes identical to that by L-DOPA (157 and 176%, respectively, of control levels). The GSH precursor, L-NAC (250 and 500 ‚aM), also induced process outgrowth identical to that with L-DOPA or GSH and increased the level of TH-positive neurons to 146 and 182%, respectively, of control levels ( Fig. 6 and Table 5 ).
If L-DOPA exerts a neurotrophic effect by potentiating the GSH pathway, process outgrowth should be inhibited by GSH synthesis inhibition. We found that a GSH synthesis inhibitor, BSO, at a level that had no effect itself (3 ‚aM for 24 h) completely inhibited the neurotrophic effects of 50 ‚aM L-DOPA (Table 6 ).
Effect of L-DOPA on glutathione levels
To determine whether L-DOPA increases intracellular GSH content, we examined GSH intracellular levels 24 h after treatment with 50 ‚aM L-DOPA using a procedure by Tietze (1969) . The assay method does not distinguish between the reduced (GSH) and oxidized (GSSG) forms of glutathione. However, GSSG normally only represents a small fraction (0.2%) of the total glutathione (Pan and Perez-Polo, 1993; Ferrari et al., 1995) , and it was previously found that L-DOPA-induced elevated glutathione levels in midbrain cultures were due predominantly to an increased GSH content (Mytilineou et al., 1993) . We found that 50 ‚aM L-DOPA increased GSH content to 137% of control levels in midbrain neurons/cortical glia cocultures (from 20.8 ± 1.3 to 28.6 ± 2.2 nmol/mg of protein; n = 8, two experiments; p < 0.01).
This study demonstrates that L-DOPA has neurotrophic effects on DA neurons, stimulates elaboration of neuntes, and protects DA neurons from cell death. These results contrast with previous studies using embryonic neurons cultured without an astrocyte layer, where L-DOPA is toxic at relatively low levels (Mena et al., 1993; Mytilineou et al., 1993; Pardo et al., 1995) . In a previous study, we found that glia-conditioned medium protects against this toxicity (Mena et al., 1996) . The present report points to a further insight, that in a coculture system using postnatal neurons and glia, L-DOPA is neurotrophic. In untreated cells the death of TH-positive neurons was similar to that in previous studies (Brugg et al., 1996) . This death rate was reduced by >50% by L-DOPA. This may provide an explanation for discrepancies between the results of L-DOPA in the various models. The neurotrophic actions of L-DOPA may underlie the longterm improved motor control after the cessation of drug administration.
Previous studies indicate that DA added to culture medium increases the expression of TH and aromatic amino acid decarboxylase in primary cultures of fetal neurons (De Vitry et al., 1991) , and the neurotransmitter itself has been postulated as a neurotrophic factor (Leslie, 1993) . Normally, L-DOPA in neuronal culture is rapidly converted to DA and taken up into synaptic vesicles (Pothos et al., 1996) . If conversion of L-DOPA to DA is required for its neurotrophic effects, the response should be blocked by the aromatic acid decarboxylase inhibitor carbidopa (Basma et al., 1995) . Our study reveals therefore that the mechanism responsible for the neurotrophic effect of L-DOPA is independent of its conversion to DA.
Astrocytes produce several neurotrophic and neurite-promoting agents (Engele et al., 1991; Nagata et al., 1993; Hoffen et al., 1994; Takeshima et al., 1994; Muller et al., 1995) that influence development, survival, neunte extension, and neurotoxin resistance (Engele et al., 1991; Nagata et al., 1993; Takeshima et al., 1994) . Among the systems identified are a glutamate uptake activity that protects against excitotoxicity (Rosenberg et al., 1991) and stimulation of GSH synthesis and enzymes involved in GSH metabolism (Nisticè et al., 1992) . GSH plays a major role in protection against oxidative stress (Meister, 1988; Makar et al., 1994 ) and functions to remove the H 202 generated by monoamine oxidase (Werner and Cohen, 1993) . GSH is produced by GSH peroxidase in culture (Raps et al., 1989) . GSH peroxidase is mainly a mitochondrial enzyme (Victonica et al., 1984) exclusively located in the human midbrain within glial cells (Slivka et al., 1987; Damier et al., 1993) . GSH levels decrease with age in neurons but remain stable in astrocytes in culture (Sagara et al., 1996) . However, neurons can maintain an intracellular glutathione poo1 by taking up cysteine provided by glial cells (Sagara et al., 1993) . Protection from oxidation enhances the survival of mesencephalic cultures (Mena et al., 1993 (Mena et al., , 1996 Pardo et al., 1995) , and the number of TH-positive neurons is increased if SOD, USH peroxidase, or L-NAC is added to the medium (Colton et al., 1995) . We have shown that TH-positive neurons that overexpress SOD display increased neutite outgrowth and survival (Przedborski et al., 1996) and are protected from L-DOPA toxicity (Mena et al., 1997) . Recently, Han et al. (1996) have reported that L-DOPA raises GSH levels in cultures of fetal rat mesencephalon, a mouse neuroblastoma line (Neuro-2A), a human neuroblastoma (SKNMC), and glia from newborn rat brain but not in midbrain neuronal cultures grown without glia.
In the present study, the effects of L-DOPA were not associated with an elevation in content of extracellular quinones, in contrast with the observations in embryonically derived, glial-free cultures (Mena et al., 1996) , suggesting that astrocytes may inhibit L-DOPA quinone formation by providing an antioxidant system. D-DOPA was not neurotrophic, although it was more effective in inducing formation of extracellular quinones. Moreover, we found that the GSH synthesis promoter L-NAC and GSH itself reproduced L-DO-PA's effects, whereas the GSH synthase inhibitor BSO blocked L-DOPA' s effect. Therefore, the present study suggests that L-DOPA is neurotrophic owing to stimulation of GSH peroxidase. It is possible that L-DOPA is sequestered intracellularly in glia by L-amino acid peroxidase.
It appears unlikely that L-DOPA provides its neurotrophic effect by acting as an antioxidant itself because high doses of L-DOPA do not provide neuroprotection and increase quinone formation; however, a cautionary note is provided by the finding that L-NAC, previously assumed to act as an antioxidant due to its role as a substrate for GSH synthesis, may protect PC12 cells by acting directly as an oxygen radical scavenger (Yan et aI., 1995) . L-NAC is a pluripotent protector that elevates the level of intracellular glutathione, prevents against apoptotic death of neuronal cells, and enhances trophic factor-mediated cell survival (Mayer and Noble, 1994; Ferrari et al., 1995) . Indeed, depletion of brain GSH with BSO in rats is accompanied by impaired mitochondrial function and decreased complex IV activity (Heales et al., 1995) leading to energy crisis as a mechanism of nigral cell death (Jenner, 1993) .
In clinical studies, GSH content is decreased in the substantia nigra of patients with idiopathic PD (Riederer et al., 1989; Sofic et al., 1992; Sian et al., 1994) . L-DOPA treatment reverses GSH depletion (Tohgi et al., 1995) . In normal subjects, the nigrostriatal DA neurons, the most important disease target associated with PD, are normally surrounded by a low density of glia (Damier et al., 1993; Sagara et al., 1993; Makar et al., 1994) , suggesting that these neurons are less protected from oxidative stress. It is striking that, in PD, the density of GSH peroxidase-positive glia surrounding the surviving DA neurons is increased, suggesting a compensatory proliferation of glia that protects surviving neurons against pathological death (Damier et al., 1993) .
Although L-DOPA is toxic for catecholamine neurons in other in vitro systems (Melamed, 1986; Mena et aI., 1992 Mena et aI., , 1993 Pardo et al., 1995) , catecholamines are required for the development of the nervous system and survival. Inactivation of the TH gene produced the death of 90% of mutant mice fetuses, whereas administration of L-DOPA to pregnant females resulted in complete rescue of mutant mice (Zhou et al., 1995) .
Transgenic animals with mutations of the TH gene have a poorer prognosis than those with mutations of the dopamine /3-hydroxylase gene (Thomas et al., 1995) , suggesting that DA is essential for development of the nervous system. It is likely that L-DOPA and catecholamines are critical factors for promoting the survival and differentiation of DA neurons and that the effects of L-DOPA on DA cells in vivo might be neurotrophic or neurotoxic depending on the local environment produced by glial cells.
In summary, conclusions from this study and that of Mena et al. (1996) indicate that a long-term potentiation of DA release by L-DOPA may occur owing to promotion of neunitic arbonization and protection against cell death. The neurotrophic effects are independent of conversion to DA and dependent on the presence of astrocytes and may result from antioxidant mechanisms such as up-regulation of GSH. Significant questions that need to be addressed include whether the effect is due to L-DOPA itself acting as an antioxi- dant or if it is due to up-regulation of a cellular system such as the GSH peroxidase pathway, whether sequestration of DA by synaptic vesicles plays a role in protection from L-DOPA toxicity, and the precise pathways of exchange of cysteine or other protective mechanisms between glial cells and DA neurons.
